| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4655b70cbfba352025a1d2393b449e77 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-16 |
| filingDate |
1981-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1981-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
GB-2068731-A |
| titleOfInvention |
Naphthyridine derivative useful in therapy and pharmaceutical compositions containing the same |
| abstract |
The compound of formula <IMAGE> and its salts are useful in therapy in the treatment of behavioural disorders attributable to cerebral vascular damage or cerebral sclerosis caused by age or of metabolic encephalopathies. They may be made into pharmaceutical compositions with appropriate carriers. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4617305-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5189041-A |
| priorityDate |
1980-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |